TP-472 is primarily utilized in the field of pharmaceutical research and development. It is being studied for its potential therapeutic effects, particularly in the treatment of various diseases. Researchers are exploring its efficacy in targeting specific biological pathways, which could lead to the development of new drugs. Additionally, TP-472 is being investigated for its role in inhibiting certain enzymes or proteins that are implicated in disease processes. This makes it a promising candidate for future medical treatments, especially in areas where current therapies are limited or ineffective. Ongoing studies aim to better understand its mechanism of action and to evaluate its safety and effectiveness in clinical settings.